AU3161300A - Use of ceramides for the treatment of cystic fibrosis - Google Patents

Use of ceramides for the treatment of cystic fibrosis

Info

Publication number
AU3161300A
AU3161300A AU31613/00A AU3161300A AU3161300A AU 3161300 A AU3161300 A AU 3161300A AU 31613/00 A AU31613/00 A AU 31613/00A AU 3161300 A AU3161300 A AU 3161300A AU 3161300 A AU3161300 A AU 3161300A
Authority
AU
Australia
Prior art keywords
ceramides
treatment
cystic fibrosis
cystic
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31613/00A
Inventor
Erich Gulbins
Florian Lang
Albrecht Lepple-Wienhues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3161300A publication Critical patent/AU3161300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU31613/00A 1999-03-03 2000-02-29 Use of ceramides for the treatment of cystic fibrosis Abandoned AU3161300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19909115 1999-03-03
DE19909115A DE19909115A1 (en) 1999-03-03 1999-03-03 Use of ceramides to treat cystic fibrosis
PCT/EP2000/001682 WO2000051578A2 (en) 1999-03-03 2000-02-29 Use of ceramides for the treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
AU3161300A true AU3161300A (en) 2000-09-21

Family

ID=7899443

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31613/00A Abandoned AU3161300A (en) 1999-03-03 2000-02-29 Use of ceramides for the treatment of cystic fibrosis

Country Status (5)

Country Link
EP (1) EP1156854A2 (en)
AU (1) AU3161300A (en)
CA (1) CA2365290A1 (en)
DE (1) DE19909115A1 (en)
WO (1) WO2000051578A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558429C (en) * 2004-03-02 2011-02-01 Mcgill University Compositions and methods for preventing or treating an inflammatory response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
DE3819870A1 (en) * 1987-06-12 1988-12-29 Hoerrmann Wilhelm Pharmaceuticals based on fatty amino alcohols
FR2658418B1 (en) * 1990-02-20 1994-09-02 Synthelabo PHARMACEUTICAL COMPOSITIONS BASED ON PHOSPHOLIPIDS.
EP1179340A3 (en) * 1994-09-30 2003-05-07 INEX Pharmaceutical Corp. Compositions for the introduction of polyanionic materials into cells
US5753613A (en) * 1994-09-30 1998-05-19 Inex Pharmaceuticals Corporation Compositions for the introduction of polyanionic materials into cells

Also Published As

Publication number Publication date
EP1156854A2 (en) 2001-11-28
WO2000051578A3 (en) 2001-01-04
DE19909115A1 (en) 2000-09-07
CA2365290A1 (en) 2000-09-08
WO2000051578A2 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
EP1180015B8 (en) Generation of therapeutic microfoam
AU2420797A (en) Novel cystic fibrosis treatment
AU2002218742A1 (en) Application of photochemotherapy for the treatment of cardiac arrhythmias
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2001260834A1 (en) The treatment of herpes
AU9664198A (en) Method for the treatment of cystic fibrosis
AU2451500A (en) Therapeutic agents
AU5547000A (en) Novel treatment
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU4556800A (en) Novel treatment
AU3899100A (en) Treatment of hyperactivity disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
AU2934200A (en) Massager for self-massage (auto-massager)
AU2042097A (en) Treatment for pulmonary fibrosis
AU5973600A (en) Therapeutic agents
AU3161300A (en) Use of ceramides for the treatment of cystic fibrosis
AU1940800A (en) Combination therapy for the treatment of sepsis
AU2566201A (en) Compounds and methods for the treatment of pain
EP1328234A4 (en) Methods for treating cystic fibrosis
AU6150200A (en) Therapeutic agents
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU5817400A (en) Therapeutic agents
AU2420201A (en) Compounds and methods for the treatment of pain
GB0103621D0 (en) The treatment of cystic fibrosis
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase